Article
Economics
Martin Connock, Peter Auguste, Xavier Armoiry
Summary: Cost-effectiveness analyses of treatments for glioblastoma multiforme have shown that models using time invariant transition probabilities tend to underestimate overall survival gain, while models incorporating Partitioned Survival approach can provide more accurate estimates of cost-effectiveness. The differences in economic model outputs between the two approaches suggest the need for more realistic estimations of costs and benefits in time invariant transition probability models.
EUROPEAN JOURNAL OF HEALTH ECONOMICS
(2021)
Article
Surgery
Amelia J. Hessheimer, Ana Magdalena Vargas-Martinez, Marta Trapero-Bertran, Miquel Navasa, Constantino Fondevila
Summary: This study evaluated the cost-effectiveness and utility of posttransplant hepatocellular carcinoma (HCC) surveillance compared to standard follow-up. Although surveillance slightly improves survival and quality of life, it also increases costs and does not appear to be cost-effective in this setting.
Article
Pharmacology & Pharmacy
Tianyu Feng, Zhou Zheng, Shang Gao, Jiaying Xu, Pen Cao, Huanhuan Jia, Xihe Yu
Summary: This study investigated the cost-effectiveness of low-dose rivaroxaban plus aspirin versus aspirin alone in patients with stable cardiovascular diseases in China. The results showed that low-dose rivaroxaban combined with aspirin therapy may be cost-effective in the secondary prevention of stable cardiovascular disease in patients.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Immunology
Coralei E. Neighbors, Evan R. Myers, Nayani P. Weerasinghe, Gaya B. Wijayaratne, Champica K. Bodinayake, Ajith Nagahawatte, L. Gayani Tillekeratne, Christopher W. Woods
Summary: Influenza vaccination is cost-effective for the Sri Lankan population, reducing cases, hospitalizations, and deaths caused by influenza. The most influential factors are vaccine coverage and effectiveness in different age groups. Providing influenza vaccines is highly cost-effective compared to not vaccinating. However, more large-scale national studies are needed to improve data and assess the impact of vaccination implementation.
Article
Pharmacology & Pharmacy
Zonglin Dai, Xi Zhang, Irene Ol Wong, Eric H. Y. Lau, Zhiming Lin
Summary: The study assessed the clinical prognosis and cost-effectiveness of treatments for lupus nephritis (LN) in China. The strategy of CYC induction followed by AZA maintenance was found to be the most cost-effective for short-term treatment, while the strategy of MMF in both induction and maintenance became cost-effective and yielded better clinical outcomes for lifetime treatment. Uncertainty analysis supported the need for monitoring the progression to end-stage renal disease (ESRD).
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Oncology
Chuan Zhang, Yue Liu, Jing Tan, Panwen Tian, Weimin Li
Summary: This study evaluated the cost-effectiveness of initial atezolizumab monotherapy versus chemotherapy for advanced non-small cell lung cancer (NSCLC) patients in the Chinese healthcare system. The results showed that atezolizumab was less cost-effective than chemotherapy in China, and reducing drug prices may improve its cost-effectiveness.
FRONTIERS IN ONCOLOGY
(2023)
Article
Ecology
Larissa Vuori, Markku Ollikainen
Summary: The study finds that removing microplastics from wastewater is technically feasible and cost-effective, with the use of a membrane bioreactor combined with sludge incineration being the most efficient option. This provides a basis for expanding government regulation to include microplastics in wastewater treatment plants, but policy targeting companies using microplastics is necessary to ultimately solve the problem.
ECOLOGICAL ECONOMICS
(2022)
Article
Public, Environmental & Occupational Health
Nan Yang, Han Yang, Jeff Jianfei Guo, Ming Hu, Sheyu Li
Summary: This study found that ultrasound screening for thyroid cancer did not have a clear advantage in terms of cost-effectiveness compared with non-screening. It is essential to optimize thyroid screening strategies for specific populations.
FRONTIERS IN PUBLIC HEALTH
(2021)
Review
Obstetrics & Gynecology
Elizabeth Martin, Bassel Ayoub, Yvette D. Miller
Summary: This systematic review aimed to identify the extent of cost-effectiveness evidence available for evaluating alternative Maternity Models of Care (MMC) and provide a narrative summary. The findings suggest weak evidence that midwife and doula models of care may be a cost-effective or cost-saving alternative to standard care. However, the poor quality of evidence, lack of standardized MMC classifications, and limited research in this area hinder conclusive evaluation.
BMC PREGNANCY AND CHILDBIRTH
(2023)
Article
Health Care Sciences & Services
Andrea Gabrio
Summary: Gathering patient-level health economic data is crucial for technology appraisal in clinical trials. Analyzing cost-effectiveness for end-of-life treatments may require partitioned survival analysis and combining quality of life measures for pre- and postprogression periods. Addressing complexities in effectiveness and cost data is important in order to avoid biased results, and a new Bayesian framework is proposed in this article to provide more adequate evidence for policy makers.
MEDICAL DECISION MAKING
(2021)
Article
Infectious Diseases
Rui Li, Hanting Liu, Christopher K. Fairley, Zhuoru Zou, Li Xie, Xinghui Li, Mingwang Shen, Yan Li, Lei Zhang
Summary: The cost-effectiveness of a booster strategy for COVID-19 vaccination in older adults in the United States was evaluated. The results show that offering a booster dose of the Pfizer-BioNTech vaccine to older adults can result in cost savings in direct medical costs and improve quality-adjusted life-years. The cost-effectiveness of the booster strategy is sensitive to the population incidence of COVID-19 and vaccine efficacies.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Obstetrics & Gynecology
Benjamin B. Albright, Evan R. Myers, Haley A. Moss, Emily M. Ko, Sarita Sonalkar, Laura J. Havrilesky
Summary: The study found that no further surveillance after the first normal human chorionic gonadotropin is the most cost-effective strategy for both complete and partial molar pregnancy due to the rarity of gestational trophoblastic neoplasia diagnosis after normalization. The costs of lost wages from societal perspective have greater impact on frequent surveillance costs than rare gestational trophoblastic neoplasia treatment costs. It would be reasonable to reduce or eliminate current recommendations for surveillance after human chorionic gonadotropin normalization after molar pregnancy.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
(2021)
Article
Public, Environmental & Occupational Health
Min Li, Yuxin Cao, Hao Huang, Gang Qin, Minjie Chu, Meiyin Zou, Xun Zhuang
Summary: This study investigates the cost-effectiveness of DTG-based regimen for treatment-naive HIV infection patients in China. The results show that DTG-based regimen has fewer adverse reactions, opportunistic infections, and deaths compared to other regimens, indicating its potential cost-effectiveness.
Article
Health Care Sciences & Services
Fernando Alarid-Escudero, Eline Krijkamp, Eva A. Enns, Alan Yang, M. G. Myriam Hunink, Petros Pechlivanoglou, Hawre Jalal
Summary: This article introduces the application of decision models in medical decision making, focusing on the time-independent cohort state-transition model (cSTM) and its implementation using R language. The article provides a detailed explanation of the model's application and calculation methods, along with open-source code in R.
MEDICAL DECISION MAKING
(2023)
Article
Pharmacology & Pharmacy
Wenxing Dong, Zhe Zhang, Mingming Chu, Peng Gu, Min Hu, Lulu Liu, Jingbin Huang, Rong Zhang
Summary: This study evaluated the cost-effectiveness of adding selexipag to the combined treatment of macitentan and tadalafil in patients with pulmonary arterial hypertension (PAH) in China. The results showed that adding selexipag increased costs but also improved quality-adjusted life years (QALYs), although the cost-effectiveness ratio was higher than the willingness-to-pay (WTP) threshold. The sensitivity analysis indicated that the results were most sensitive to mortality rates, discount rate, and the cost of selexipag.
FRONTIERS IN PHARMACOLOGY
(2023)
Review
Oncology
D. De Ruysscher, B. Lueza, C. Le Pechoux, D. H. Johnson, M. O'Brien, N. Murray, S. Spiro, X. Wang, M. Takada, B. Lebeau, W. Blackstock, D. Skarlos, P. Baas, H. Choy, A. Price, L. Seymour, R. Arriagada, J. -P. Pignon
ANNALS OF ONCOLOGY
(2016)
Article
Oncology
N. Lassau, B. Coiffier, M. Kind, V. Vilgrain, J. Lacroix, M. Cuinet, S. Taieb, R. Aziza, A. Sarran, C. Labbe-Devilliers, B. Gallix, O. Lucidarme, Y. Ptak, L. Rocher, L. M. Caquot, S. Chagnon, D. Marion, A. Luciani, S. Feutray, J. Uzan-Augui, B. Benatsou, J. Bonastre, S. Koscielny
ANNALS OF ONCOLOGY
(2016)
Article
Oncology
Simone Benhamou, Julia Bonastre, Karine Groussard, Francois Radvanyi, Yves Allory, Thierry Lebret
Article
Health Care Sciences & Services
Beranger Lueza, Federico Rotolo, Julia Bonastre, Jean-Pierre Pignon, Stefan Michiels
BMC MEDICAL RESEARCH METHODOLOGY
(2016)
Correction
Health Care Sciences & Services
Beranger Lueza, Federico Rotolo, Julia Bonastre, Jean-Pierre Pignon, Stefan Michiels
BMC MEDICAL RESEARCH METHODOLOGY
(2016)
Article
Oncology
E. Rococo, C. Mazouni, Z. Or, V. Mobillion, M. Koon Sun Pat, J. Bonastre
Article
Oncology
Suzette Delaloge, Julia Bonastre, Isabelle Borget, Jean-Remi Garbay, Rachel Fontenay, Diane Boinon, Mahasti Saghatchian, Marie-Christine Mathieu, Chafika Mazouni, Sofia Rivera, Catherine Uzan, Fabrice Andre, Clarisse Dromain, Bruno Boyer, Barbara Pistilli, Sandy Azoulay, Francoise Rimareix, El-Hadi Bayou, Benjamin Sarfati, Helene Caron, Amal Ghouadni, Nicolas Leymarie, Sandra Canale, Muriel Mons, Julia Arfi-Rouche, Monica Arnedos, Voichita Suciu, Philippe Vielh, Corinne Balleyguier
EUROPEAN JOURNAL OF CANCER
(2016)
Article
Genetics & Heredity
Arnaud Pages, Stephanie Foulon, Zhaomin Zou, Ludovic Lacroix, Francois Lemare, Thierry de Baere, Christophe Massard, Jean-Charles Soria, Julia Bonastre
GENETICS IN MEDICINE
(2017)
Article
Health Care Sciences & Services
Patricia Guyot, Anthony E. Ades, Matthew Beasley, Beranger Lueza, Jean-Pierre Pignon, Nicky J. Welton
MEDICAL DECISION MAKING
(2017)
Review
Oncology
Catherine Lejeune, Beranger Lueza, Julia Bonastre
BULLETIN DU CANCER
(2018)
Article
Oncology
Marc Delord, Stephanie Foulon, Jean-Michel Cayuela, Philippe Rousselot, Julia Bonastre
Review
Public, Environmental & Occupational Health
J. Margier, S. Baffert, A. -G. Le Corroller-Soriano, S. Baffert, A. -C. Bertaux, J. Bonastre, N. Costa, F. Denies, B. Dervaux, C. Dutot, P. Guerre, N. Havet, N. Hayes, A. -G. Le Corroller Soriano, C. Lejeune, B. Lueza, J. Margier, G. Mercier, M. Morelle, L. Perrier, A. Pages, M. Plantier, V. -P. Riche
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
(2018)
Review
Public, Environmental & Occupational Health
G. Mercier, N. Costa, C. Dutot, V. -P. Riche, S. Baffert, A. -C. Bertaux, J. Bonastre, N. Costa, F. Denies, B. Dervaux, C. Dutot, P. Guerre, N. Havet, N. Hayes, A. -G. Le Corroller-Soriano, C. Lejeune, B. Lueza, J. Margier, G. Mercier, M. Morelle, L. Perrier, A. Pages, M. Plantier, V. -P. Riche
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
(2018)
Editorial Material
Public, Environmental & Occupational Health
L. Perrier, S. Baffert, A. -C. Bertaux, J. Bonastre, N. Costa, F. Denies, B. Dervaux, C. Dutot, P. Guerre, N. Havet, N. Hayes, A. -G. Le Corroller-Soriano, C. Lejeune, B. Lueza, J. Margier, G. Mercier, M. Morelle, L. Perrier, A. Pages, M. Plantier, V. -P. Riche
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
(2018)
Article
Oncology
Angelica Conversano, Chafika Mazouni, Anne Thomin, Amelie Gaudin, Marie Fournier, Francoise Rimareix, Julia Bonastre
CLINICAL BREAST CANCER
(2017)
